STAAR Surgical Company (NASDAQ:STAA) Recent Earnings Shows Major Promise

STAAR Surgical Company (NASDAQ:STAA) Recent Earnings Shows Major Promise


The STAAR Surgical Company (STAA) shares are trading at higher $60.01 and the avg recommendation for the stock is Strong Buy. The current analyst price target stands at $49.00.

To add more color to this target, the company’s high over the last year is $61.73 and the low is $23.20. Over the last 52 weeks, STAA is down -2.79% while the S&P 500 is up 1.07%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, STAA reported a profit of $24.76 million. STAAR Surgical Company also saw revenues increase to $35.19 million. In addition, STAA has free cash flow of -$10.36 million as of 03-2020 The company’s EBITDA came in at -$0.36 million which compares well with its peers.

STAA booked profit margins of 8.20%, its Return on Equity (ROE) is 8.10%, and its Return on Assets is 6.30%. All told, it is clear that, STAA needs to be on your watchlist.

Find out when STAA reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. STAA has a short ratio of 4.27 and outstanding shares of 44.95M.

Company Outlook

STAA has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.05 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.27. STAAR Surgical Company STAA also noted assets of $206.79 million at the end of the last quarter. Investors should also keep an eye on sector updates as STAA has historically followed its peers on positive news.

All told, STAAR Surgical Company STAA has strung together solid data and demonstrated underlying fundamentals. At its current valuation, STAA represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

STAAR Surgical Company STAA is now commanding a market cap of 2.52B and a float of 30.59M. STAA is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of STAA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in STAA, either long or short, and we have not been compensated for this article.